Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Leucine-rich repeat and fibronectin type III domain-containing protein 1 (529-579 aa) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
LRFN1 |
Gene ID: |
57622 |
Uniprot ID: |
LRFN1_HUMAN |
Immunogen Region: |
529-579 aa |
Specificity: |
This antibody detects endogenous levels of LRFN1 at Human/Mouse/Rat |
Immunogen: |
Synthesized peptide derived from the human LRFN1 at the amino acid range 529-579 |
Function | Promotes neurite outgrowth in hippocampal neurons. Involved in the regulation and maintenance of excitatory synapses. Induces the clustering of excitatory postsynaptic proteins, including DLG4, DLGAP1, GRIA1 and GRIN1. |
Protein Name | Leucine-Rich Repeat And Fibronectin Type Iii Domain-Containing Protein 1Synaptic Adhesion-Like Molecule 2 |
Database Links | Reactome: R-HSA-8849932 |
Cellular Localisation | MembraneSingle-Pass Type I Membrane ProteinSynapsePostsynaptic Density MembraneDetected In ExcitatoryBut Not InhibitorySynaptic Plasma Membrane |
Alternative Antibody Names | Anti-Leucine-Rich Repeat And Fibronectin Type Iii Domain-Containing Protein 1 antibodyAnti-Synaptic Adhesion-Like Molecule 2 antibodyAnti-LRFN1 antibodyAnti-KIAA1484 antibodyAnti-SALM2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance